Cowen reiterates an Outperform rating on CVS Health (NYSE: CVS), and raised the price target to $116.00 (from $108.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

CVS Health (CVS) to Acquire TGT Pharmacies for $1.9B; Cowen Reiterates OutperformJune 15, 2015 11:20 AM CVS Health (CVS) to Acquire Target's (TGT) Pharmacy, Clinic Business in ~$1.9B DealJune 15, 2015 7:01 AM Macquarie Starts CVS Health (CVS) at OutperformJune 9, 2015 6:48 AM